Reply to Commentary on “Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma”

Author: San-Gang WU ¹
Author Information

1. Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
Publication Type:Correspondence
From:Cancer Research and Treatment 2025;57(1):291-292
CountryRepublic of Korea
Language:English